Key result
Direct-to-consumer wearables offer innovative CVD management but risk unreliable data and worsening health disparities.
Why the study?
The increasing popularity of direct-to-consumer wearables in cardiovascular health management raises challenges related to data reliability, interpretation, psychological impact, and health disparities.
Direct-to-consumer wearables offer potential benefits for continuous cardiovascular care but present challenges regarding data reliability, clinical actionability, and health disparities.
Answers are grounded in this paper and cite their sources.
Clinicians should interpret consumer wearable data cautiously amid reliability and equity risks; leaves open key questions on validation and system integration.
Direct-to-consumer (D2C) wearables are becoming increasingly popular in cardiovascular health management because of their affordability and capability to capture diverse health data. Wearables may enable continuous health care provider-patient partnerships and reduce the volume of episodic clinic-based care (thereby reducing health care costs). However, challenges arise from the unregulated use of these devices, including questionable data reliability, potential misinterpretation of information, unintended psychological impacts, and an influx of clinically nonactionable data that may overburden the health care system. Further, these technologies could exacerbate, rather than mitigate, health disparities. Experience with wearables in atrial fibrillation underscores these challenges. The prevalent use of D2C wearables necessitates a collaborative approach among stakeholders to ensure effective integration into cardiovascular care. Wearables are heralding innovative disease screening, diagnosis, and management paradigms, expanding therapeutic avenues, and anchoring personalized medicine.
No takes yet. Share an insight, caveat, or question.
Varma et al. (2024) conducted a review in Cardiovascular health. Direct-to-consumer (D2C) wearables was evaluated. Direct-to-consumer wearables offer innovative cardiovascular disease management paradigms but present challenges including questionable data reliability and potential to exacerbate health disparities.
Synapse has enriched 10 related papers. Consider them for comparative context: